KeyBanc analyst Aleksey Yefremov raised the firm’s price target on Livent to $35 from $32 and keeps an Overweight rating on the shares. The firm is becoming increasingly more confident in the level of lithium prices given the continued recovery of demand globally as well as supply delays, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LTHM: